Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Roberta Madej"'
Autor:
Jinwei Du, Dayu Zhang, Joseph A. Pathakamuri, Daniel Kuebler, Ying Yang, Yulia Loginova, Eric Chu, Roberta Madej, Jocelyn V. Neves, Brianna Singer, Holly Radke, Naomi Spencer, Elizabeth Rizk, Aiguo Zhang, Chuanyi M. Lu, Michael Y. Sha
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 250-259 (2022)
Testing and vaccination have been major components of the strategy for combating the ongoing COVID-19 pandemic. In this study, we have developed a quantitative anti-SARS-CoV-2 spike (S1) IgG antibody assay using a fingerstick dried blood sample. We e
Externí odkaz:
https://doaj.org/article/a2a7d7c52c8b40db9c090c72e0755f37
Autor:
Qing Sun, Jonathan Li, Hui Ren, Larry Pastor, Yulia Loginova, Roberta Madej, Kristopher Taylor, Joseph K Wong, Zhao Zhang, Aiguo Zhang, Chuanyi M Lu, Michael Y Sha
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0243183 (2021)
BackgroundSensitive and high throughput molecular detection assays are essential during the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vast majority of the SARS-CoV-2
Externí odkaz:
https://doaj.org/article/c51f42a3d8e44a04950dc788b5fd6ccc
Autor:
Daniel Kuebler, Dayu Zhang, Hannah May, Joseph Pathakamuri, Michael Y. Sha, Yulia Loginova, Jocelyn V Neves, Aiguo Zhang, Jinwei Du, Eric Chu, Chuanyi M. Lu, Roberta Madej
Among several COVID vaccines that have been approved, the Moderna and Pfizer-BioNTech vaccines are mRNA vaccines that are safe and highly effective at preventing COVID-19 illness. Studies have demonstrated that neutralizing antibody responses elicite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cd1b912d2c38625c48405e38cbf6656
https://doi.org/10.1101/2021.04.11.21255278
https://doi.org/10.1101/2021.04.11.21255278
Autor:
Joseph K. Wong, Michael Y. Sha, Aiguo Zhang, Jonathan C. Li, Hui Ren, Larry Pastor, Zhao Zhang, Yulia Loginova, Chuanyi M. Lu, Roberta Madej, Kristopher Taylor, Qing Sun
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0243183 (2021)
PLoS ONE
PLoS ONE
Background Sensitive and high throughput molecular detection assays are essential during the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vast majority of the SARS-CoV-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99613d13d8fae64c56ef8e3bf6b1402e
https://doaj.org/article/c51f42a3d8e44a04950dc788b5fd6ccc
https://doaj.org/article/c51f42a3d8e44a04950dc788b5fd6ccc
Publikováno v:
J Clin Virol
In 2018, a bi-partisan proposed draft legislation called the Verifying Accurate, Leading-edge IVCT Development (VALID) Act was released by Representative Larry Bucshon (Republican-Indiana) and Diana DeGette, (Democrat-Colorado). The VALID Act attempt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa9b026121b5729389be949b4333cefe
https://doi.org/10.1016/j.jcv.2021.104875
https://doi.org/10.1016/j.jcv.2021.104875
Publikováno v:
J Clin Virol
Respiratory tract infections are a common cause of visits to emergency departments and outpatient settings. Infections with influenza viruses A and B in particular, are responsible for significant morbidity and mortality in both pediatric and adult p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bed332d9f542eba46c7881f80147ac8
https://pubmed.ncbi.nlm.nih.gov/31102924
https://pubmed.ncbi.nlm.nih.gov/31102924
Autor:
Roberta Madej
Publikováno v:
Molecular Diagnosis. 6:335-345
Ten years ago, laboratory directors introducing molecular infectious disease diagnostics in the routine clinical setting had few resources to assist in their implementation and quality assurance programs. In the past 10 years, several organizations h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d7758930aff5d72492fe9159223f48f
https://doi.org/10.1054/modi.2001.29159
https://doi.org/10.1054/modi.2001.29159
Autor:
George J. Schneider, Marcia J. Holden, Roberta Madej, Stan Kwang, Emmanuel Labourier, Jack Davis
The utility of quantitative molecular diagnostics for patient management depends on the ability to relate patient results to prior results or to absolute values in clinical practice guidelines. To do this, those results need to be comparable across t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7bb5abdba0730123253fc7caf3e3b07
https://europepmc.org/articles/PMC2871718/
https://europepmc.org/articles/PMC2871718/
Publikováno v:
Molecular Diagnosis. 3:127-129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bff110a59ac856ba52879adc5cf20c6
https://doi.org/10.1016/s1084-8592(98)80030-1
https://doi.org/10.1016/s1084-8592(98)80030-1
Publisher Summary This chapter discusses the clinical applications of polymerase chain reaction (PCR). The chapter identifies those diseases for which the PCR offers an advantage over conventional diagnostic methods—for example, it may be the prefe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f54009963e51a146091ba54c8ac54f6
https://doi.org/10.1016/s0065-2423(08)60224-3
https://doi.org/10.1016/s0065-2423(08)60224-3